{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:11:46Z","timestamp":1791259906727,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1.8.029.20 N"],"award-info":[{"award-number":["1.8.029.20 N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.autrev.2021.102796","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:50:54Z","timestamp":1615683054000},"page":"102796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system"],"prefix":"10.1016","volume":"20","author":[{"given":"Elvis","family":"Hysa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Gotelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Paolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Amedeo","family":"Cimmino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pizzorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Sulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9894","key":"10.1016\/j.autrev.2021.102796_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt","year":"2013","journal-title":"Lancet."},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0010","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41584-020-0503-4","article-title":"Sex steroids and autoimmune rheumatic diseases: state of the art","volume":"16","author":"Cutolo","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10067-016-3481-9","article-title":"Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey","volume":"36","author":"GEO-RA Group","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2021.102796_bb0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nrrheum.2010.86","article-title":"Geoepidemiology of autoimmune rheumatic diseases","volume":"6","author":"Shapira","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","article-title":"Primary Sj\u00f6gren\u2019s syndrome and the eye","volume":"65","author":"Bjordal","year":"2020","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bjophthalmol-2015-306629","article-title":"Ocular manifestations in systemic lupus erythematosus","volume":"100","author":"Silpa-archa","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2021.102796_bb0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.57.8.447","article-title":"Ophthalmic manifestations of dermatomyositis","volume":"57","author":"Backhouse","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.semarthrit.2018.12.007","article-title":"Ocular involvement in systemic sclerosis: a systematic literature review, it\u2019s not all scleroderma that meets the eye","volume":"49","author":"Kreps","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10067-012-2078-1","article-title":"Retinal vasculitis in rheumatic diseases: an unseen burden","volume":"32","author":"Androudi","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2021.102796_bb0055","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.autrev.2017.10.010","article-title":"Uveitis: diagnostic work-up. A literature review and recommendations from an expert committee","volume":"16","author":"S\u00e8ve","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102796_bb0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.12688\/f1000research.10587.1","article-title":"Recent advances in managing and understanding uveitis","volume":"6","author":"Chen","year":"2017","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"Focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2017.10.018","article-title":"Heron E et al contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (uveitis: clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis)","volume":"17","author":"Grumet","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102796_bb0075","doi-asserted-by":"crossref","first-page":"c4976","DOI":"10.1136\/bmj.c4976","article-title":"Investigation and management of uveitis","volume":"341","author":"Guly","year":"2010","journal-title":"BMJ."},{"issue":"Pt 2","key":"10.1016\/j.autrev.2021.102796_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/eye.1997.49","article-title":"The distribution of immune cells in the uveal tract of the normal eye","volume":"11","author":"McMenamin","year":"1997","journal-title":"Eye (Lond)"},{"issue":"3\u20134","key":"10.1016\/j.autrev.2021.102796_bb0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00424-017-1947-5","article-title":"Macrophage physiology in the eye","volume":"469","author":"Chinnery","year":"2017","journal-title":"Pflugers Arch"},{"issue":"9","key":"10.1016\/j.autrev.2021.102796_bb0090","doi-asserted-by":"crossref","first-page":"102351","DOI":"10.1016\/j.autrev.2019.102351","article-title":"Uveitis: Autoimmunity\u2026 and beyond","volume":"18","author":"Bertrand","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nri1224","article-title":"Ocular immune privilege: therapeutic opportunities from an experiment of nature","volume":"3","author":"Streilein","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2021.102796_bb0100","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/08820139.2014.910024","article-title":"Immunological aspects of corneal transplant","volume":"43","author":"Kumar","year":"2014","journal-title":"Immunol Investig"},{"key":"10.1016\/j.autrev.2021.102796_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1679197","article-title":"Immune privilege and eye-derived T-regulatory cells","volume":"2018","author":"Keino","year":"2018","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1615\/CritRevImmunol.v22.i1.20","article-title":"Immune privilege in the anterior chamber of the eye","volume":"22","author":"Niederkorn","year":"2002","journal-title":"Crit Rev Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.it.2008.08.002","article-title":"Immune regulation and the eye","volume":"29","author":"Stein-Streilein","year":"2008","journal-title":"Trends Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2021.102796_bb0120","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0125","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.4049\/jimmunol.178.11.6994","article-title":"Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells","volume":"178","author":"Futagami","year":"2007","journal-title":"J Immunol"},{"issue":"Suppl. 6","key":"10.1016\/j.autrev.2021.102796_bb0130","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5301\/EJO.2010.6049","article-title":"Blood-retinal barrier","volume":"21","author":"Cunha-Vaz","year":"2011","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2021.102796_bb0135","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.autrev.2017.03.006","article-title":"Relevance of diagnostic investigations in patients with uveitis: retrospective cohort study on 300 patients","volume":"16","author":"Hadjadj","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102796_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/941346","article-title":"Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases","volume":"2012","author":"Takakubo","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2021.102796_bb0145","first-page":"102731","article-title":"Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment","volume":"14","author":"Br\u00fcner","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis."},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.autrev.2015.12.001","article-title":"The autoimmune diseases of the eyes","volume":"15","author":"de Andrade","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102796_bb0160","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.autrev.2018.09.011","article-title":"Take a look at the eyes in systemic lupus Erythematosus: a novel point of view","volume":"18","author":"Conigliaro","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0170","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0002-9394(70)91052-4","article-title":"Experimental acute immunologic ocular vasculitis","volume":"69","author":"Levine","year":"1970","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.autrev.2021.102796_bb0175","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/art.1780310904","article-title":"Lupus retinopathy. Patterns, associations, and prognosis","volume":"31","author":"Stafford-Brady","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2021.102796_bb0180","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/rheumatology\/kem173","article-title":"Ocular manifestations of systemic lupus erythematosus","volume":"46","author":"Sivaraj","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0185","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/ICU.0b013e3283126d34","article-title":"Ocular manifestations of systemic lupus erythematosus","volume":"19","author":"Davies","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"10.1016\/j.autrev.2021.102796_bb0190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/ard.59.9.705","article-title":"Retinal disease in patients with systemic lupus erythematosus","volume":"59","author":"Ushiyama","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0195","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archinte.1979.03630480084026","article-title":"Immune-complex deposition in the eye in systemic lupus erythematosus","volume":"139","author":"Aronson","year":"1979","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.autrev.2021.102796_bb0200","doi-asserted-by":"crossref","first-page":"102371","DOI":"10.1016\/j.autrev.2019.102371","article-title":"Systemic lupus erythematosus and hypertension","volume":"18","author":"Munguia-Realpozo","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5152\/eurjrheum.2015.0085","article-title":"The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus","volume":"3","author":"\u00dcnl\u00fc","year":"2016","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102796_bb0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/1874312901812010171","article-title":"SLE and serum complement: causative, concomitant or coincidental?","volume":"12","author":"Sandhu","year":"2018","journal-title":"Open Rheumatol J"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2249.1991.tb05714.x","article-title":"Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis","volume":"85","author":"D\u2019Cruz","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1568-9972(02)00063-0","article-title":"Antiendothelial cell antibodies in systemic lupus erythematosus","volume":"1","author":"Renaudineau","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102796_bb0225","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9680729","article-title":"Endothelial alterations in systemic lupus erythematosus and rheumatoid arthritis: potential effect of monocyte interaction","volume":"2017","author":"Atehort\u00faa","year":"2017","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.autrev.2021.102796_bb0230","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1749-6632.2009.04632.x","article-title":"In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes","volume":"1173","author":"Clemens","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.autrev.2021.102796_bb0235","doi-asserted-by":"crossref","first-page":"102615","DOI":"10.1016\/j.autrev.2020.102615","article-title":"Beyond current concepts in anti-phospholipid syndrome: the 16th international congress on anti-phospholipid antibodies (ICAPA) in Manchester","volume":"19","author":"Chighizola","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102796_bb0240","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3389\/fphys.2018.01840","article-title":"Mechanisms of endothelial dysfunction in antiphospholipid syndrome: association with clinical manifestations","volume":"9","author":"Vel\u00e1squez","year":"2018","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.autrev.2021.102796_bb0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0036-1597286","article-title":"New insights in the pathophysiology of antiphospholipid syndrome","volume":"44","author":"Sacharidou","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"10.1016\/j.autrev.2021.102796_bb0250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/0961203309103062","article-title":"Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?","volume":"18","author":"Pericleous","year":"2009","journal-title":"Lupus."},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/tjh.2015.0197","article-title":"The role of complement inhibition in thrombotic angiopathies and antiphospholipid syndrome","volume":"33","author":"Erkan","year":"2016","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.autrev.2021.102796_bb0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"\u03b22-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0265","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.102796_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/948364","article-title":"Interferon alpha in systemic lupus erythematosus","volume":"2010","author":"Niewold","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MAJ.0000000000000284","article-title":"Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms","volume":"348","author":"Jones Buie","year":"2014","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.autrev.2021.102796_bb0280","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/BOR.0b013e3283546703","article-title":"Lupus neutrophils: \u2018NET\u2019 gain in understanding lupus pathogenesis","volume":"24","author":"Knight","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"21","key":"10.1016\/j.autrev.2021.102796_bb0285","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.autrev.2021.102796_bb0290","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrrheum.2011.132","article-title":"Neutrophils in the pathogenesis and manifestations of SLE","volume":"7","author":"Kaplan","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0295","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0300","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2012.14","article-title":"Accelerated atherosclerosis in patients with SLE \u2013 Mechanisms and management","volume":"8","author":"Skaggs","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"8925","key":"10.1016\/j.autrev.2021.102796_bb0305","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(94)92346-9","article-title":"The oxidation hypothesis of atherosclerosis","volume":"344","author":"Witztum","year":"1994","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0310","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/archopht.118.4.588","article-title":"Occlusive retinal vasculitis associated with systemic lupus erythematosus","volume":"118","author":"Read","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0315","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0961203309345751","article-title":"Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus and anti-phospholipid syndrome","volume":"19","author":"Chang","year":"2010","journal-title":"Lupus."},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0320","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ajo.2014.09.001","article-title":"Purtscher-like retinopathy in systemic lupus erythematosus","volume":"158","author":"Wu","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0325","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1191\/096120300680199024","article-title":"Choroidopathy of systemic lupus erythematosus","volume":"9","author":"Nguyen","year":"2000","journal-title":"Lupus."},{"issue":"7","key":"10.1016\/j.autrev.2021.102796_bb0330","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0161-6420(98)97015-4","article-title":"Angle-closure glaucoma as an initial presentation of systemic lupus erythematosus","volume":"105","author":"Wisotsky","year":"1998","journal-title":"Ophthalmology."},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0335","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.autrev.2019.102452","article-title":"Outcomes of limited cutaneous systemic sclerosis patients: results on more than 12,000 patients from the EUSTAR database","volume":"19","author":"Frantz","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0340","doi-asserted-by":"crossref","first-page":"102713","DOI":"10.1016\/j.autrev.2020.102713","article-title":"The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: systematic review and meta-analysis","volume":"20","author":"Rubio-Rivas","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2021.102796_bb0345","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2021.102796_bb0350","first-page":"1","article-title":"A wide Spectrum of ocular manifestations signify patients with systemic sclerosis","volume":"2","author":"Szucs","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0355","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10792-015-0165-4","article-title":"Anterior segment parameters and eyelids in systemic sclerosis","volume":"36","author":"Sahin Atik","year":"2016","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0360","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1590\/S1807-59322011000300003","article-title":"Ocular findings in patients with systemic sclerosis","volume":"66","author":"Gomes Bde","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0365","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/ard.62.3.204","article-title":"Retinal findings in systemic sclerosis: a comparison with nailfold capillaroscopic patterns","volume":"62","author":"Ushiyama","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2021.102796_bb0370","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.3899\/jrheum.140624","article-title":"Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases","volume":"41","author":"Rotondo","year":"2014","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0375","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41433-019-0591-z","article-title":"Analysis of retinal and choroidal microvasculature in systemic sclerosis: an optical coherence tomography angiography study","volume":"34","author":"K\u0131l\u0131n\u00e7 Hekimsoy","year":"2020","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0380","first-page":"251","article-title":"Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?","volume":"38","author":"Gomes","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.autrev.2021.102796_bb0385","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mvr.2014.08.008","article-title":"Meroni PL; ACUTE study group; ACUTE study group. Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study","volume":"97","author":"Ingegnoli","year":"2015","journal-title":"Microvasc Res"},{"issue":"7","key":"10.1016\/j.autrev.2021.102796_bb0390","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.autrev.2016.03.005","article-title":"Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","volume":"15","author":"Cabral-Marques","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0395","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1167\/iovs.08-2460","article-title":"Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects","volume":"50","author":"Resch","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.autrev.2021.102796_bb0400","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/eye.2017.74","article-title":"Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy","volume":"31","author":"Khuu","year":"2017","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0405","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/jcm9030824","article-title":"Endothelin receptor antagonists: status quo and future perspectives for targeted therapy","volume":"9","author":"Enevoldsen","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0410","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.bjp.0706193","article-title":"Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1","volume":"145","author":"Dong","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2021.102796_bb0415","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.preteyeres.2017.12.001","article-title":"Neural control of choroidal blood flow","volume":"64","author":"Reiner","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0420","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.exer.2010.09.006","article-title":"Endothelin, astrocytes and glaucoma","volume":"93","author":"Prasanna","year":"2011","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0425","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.5114\/aoms.2013.39217","article-title":"Prevalence of ocular manifestations in systemic sclerosis patients","volume":"9","author":"Waszczykowska","year":"2013","journal-title":"Arch Med Sci"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0430","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/ard.36.2.152","article-title":"Involvement of the eye in SLE and scleroderma. A study using fluorescein angiography in addition to clinical ophthalmic assessment","volume":"36","author":"Grennan","year":"1977","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2021.102796_bb0435","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000265512","article-title":"Fundus fluorescein angiography in generalized scleroderma","volume":"19","author":"Serup","year":"1987","journal-title":"Ophthalmic Res"},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0440","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3109\/02713689508998523","article-title":"Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts","volume":"14","author":"Kvanta","year":"1995","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2021.102796_bb0445","series-title":"Vitreo-retinal surgery","article-title":"Retinal pigment epithelium differentiation and dedifferentiation","author":"Sheridan","year":"2005"},{"issue":"5","key":"10.1016\/j.autrev.2021.102796_bb0450","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0002-9394(72)91208-1","article-title":"The choroidopathy of progressive systemic sclerosis (scleroderma)","volume":"74","author":"Farkas","year":"1972","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0455","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2340\/00015555528193","article-title":"Ultrastructure of generalized scleroderma","volume":"52","author":"Kobayasi","year":"1972","journal-title":"Acta Derm Venereol"},{"issue":"10 Pt 2","key":"10.1016\/j.autrev.2021.102796_bb0460","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.lpm.2014.02.031","article-title":"Kidney involvement in systemic sclerosis","volume":"43","author":"Steen","year":"2014","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0465","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.exer.2004.02.012","article-title":"Investigations for retinopathy in an avian model for systemic sclerosis","volume":"79","author":"Peter","year":"2004","journal-title":"Exp Eye Res"},{"issue":"9","key":"10.1016\/j.autrev.2021.102796_bb0470","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s10067-019-04716-w","article-title":"Nailfold capillaroscopy in rheumatology: ready for the daily use but with care in terminology","volume":"38","author":"Cutolo","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0475","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0480","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/rheumatology\/ket153","article-title":"State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?","volume":"52","author":"Cutolo","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2021.102796_bb0485","doi-asserted-by":"crossref","first-page":"102619","DOI":"10.1016\/j.autrev.2020.102619","article-title":"May capillaroscopy be a candidate tool in future algorithms for SSC-ILD: are we looking for the holy grail? A systematic review","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"10055","key":"10.1016\/j.autrev.2021.102796_bb0490","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0495","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semarthrit.2006.04.006","article-title":"Systemic rheumatoid vasculitis: a review","volume":"36","author":"Genta","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0500","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/BOR.0b013e32831c5303","article-title":"Vasculitis in rheumatoid arthritis","volume":"21","author":"Turesson","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102796_bb0505","first-page":"102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"17","author":"Conforti","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0510","first-page":"472","volume":"98","author":"Fong","year":"1991","journal-title":"Immunopathol Scleritis Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0515","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000310151","article-title":"Retinal vasculitis as a complication of rheumatoid arthritis","volume":"201","author":"Matsuo","year":"1990","journal-title":"Ophthalmologica."},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0520","first-page":"121","article-title":"Retinal vasculitis in rheumatoid arthritis: an angiographic study","volume":"8","author":"Giordano","year":"1990","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0525","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-5155(97)00102-0","article-title":"Geographic choroiditis and retinal vasculitis in rheumatoid arthritis","volume":"42","author":"Matsuo","year":"1998","journal-title":"Jpn J Ophthalmol"},{"issue":"6278","key":"10.1016\/j.autrev.2021.102796_bb0530","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1136\/bmj.282.6278.1745","article-title":"Retinal vasculitis in rheumatoid arthritis","volume":"282","author":"Martin","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.autrev.2021.102796_bb0535","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2021.102796_bb0540","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajo.2018.04.004","article-title":"How are ocular signs and symptoms of dry eye associated with depression in women with and without sj\u00f6gren syndrome?","volume":"191","author":"Gonzales","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0545","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cxo.12307","article-title":"Retinal vasculitis associated with autoantibodies of primary Sj\u00f6gren\u2019s syndrome after cataract surgery","volume":"99","author":"Lim","year":"2016","journal-title":"Clin Exp Optom"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0550","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0002-9394(14)73373-2","article-title":"Retinal vasculitis associated with autoantibodies to Sj\u00f6gren\u2019s syndrome a antigen","volume":"100","author":"Farmer","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0555","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10384-014-0327-3","article-title":"Relationship between retinal morphological findings and autoantibody profile in primary Sj\u00f6gren\u2019s syndrome","volume":"58","author":"Yang","year":"2014","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157995","article-title":"Analysis of clinical factors associated with retinal morphological changes in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0565","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0961203311434938","article-title":"Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE","volume":"21","author":"Ahlin","year":"2012","journal-title":"Lupus."},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0570","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1172\/JCI114918","article-title":"Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sj\u00f6gren\u2019s syndrome","volume":"86","author":"Gerli","year":"1990","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057557","article-title":"Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina","volume":"8","author":"Gramlich","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0580","doi-asserted-by":"crossref","first-page":"102535","DOI":"10.1016\/j.autrev.2020.102535","article-title":"Glaucoma is an autoimmune disease","volume":"19","author":"Geyer","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0585","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s13167-017-0107-5","article-title":"The potential relationship between Flammer and Sj\u00f6gren syndromes: the chime of dysfunction","volume":"8","author":"Baban","year":"2017","journal-title":"EPMA J"},{"issue":"6","key":"10.1016\/j.autrev.2021.102796_bb0590","first-page":"937","article-title":"One year in review 2018: idiopathic inflammatory myopathies","volume":"36","author":"Marasco","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.102796_bb0595","first-page":"282","article-title":"Retinitis in dermatomyositis","volume":"36","author":"Bruce","year":"1938","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0600","first-page":"177","article-title":"Retinopathy of dermatomyositis","volume":"5","author":"Cohen","year":"1985","journal-title":"J Clin Neuroophthalmol"},{"issue":"3","key":"10.1016\/j.autrev.2021.102796_bb0605","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/rheumatology\/keh040","article-title":"Visual loss from optic neuropathy in dermatomyositis","volume":"43","author":"Foroozan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102796_bb0610","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2415-13-36","article-title":"Purtscher-like retinopathy associated with dermatomyositis","volume":"13","author":"Yan","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.autrev.2021.102796_bb0615","series-title":"Purtscher retinopathy","author":"Ribeiro","year":"2020"},{"issue":"1","key":"10.1016\/j.autrev.2021.102796_bb0620","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00171460","article-title":"Purtscher\u2019s disease","volume":"44","author":"Baarsma","year":"1977","journal-title":"Doc Ophthalmol"},{"issue":"7","key":"10.1016\/j.autrev.2021.102796_bb0625","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3899\/jrheum.181275","article-title":"Endothelial activation markers as disease activity and damage measures in juvenile dermatomyositis","volume":"47","author":"Kishi","year":"2020","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2021.102796_bb0630","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/08916930903002511","article-title":"Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies","volume":"42","author":"Grundtman","year":"2009","journal-title":"Autoimmunity."},{"issue":"2","key":"10.1016\/j.autrev.2021.102796_bb0635","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2005.05.008","article-title":"Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis","volume":"5","author":"Sallum","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2021.102796_bb0640","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann Neurol"},{"issue":"6781","key":"10.1016\/j.autrev.2021.102796_bb0645","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/bmj.302.6781.880-a","article-title":"Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease","volume":"302","author":"Cervera","year":"1991","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.autrev.2021.102796_bb0650","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0655","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.4049\/jimmunol.1101284","article-title":"Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus","volume":"187","author":"Kahlenberg","year":"2011","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2021.102796_bb0660","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/rheumatology\/kew288","article-title":"Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis","volume":"55","author":"Ekholm","year":"2016","journal-title":"Rheumatology (Oxford)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:21:25Z","timestamp":1761600085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":132,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1568997221000604"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102796","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102796"}}